(1) | (2) | (3) | |
All | 95% CI | No of facilities | |
Share of clinics with at least one health worker that can correctly diagnose and prescribe treatment for | |||
Diarrhoea | 68.7% | 0.66 to 0.72 | 7910 |
Pneumonia | 61.5% | 0.59 to 0.64 | 7910 |
Malaria | 90.2% | 0.88 to 0.93 | 4799 |
Neonatal asphyxia | 70.5% | 0.68 to 0.73 | 7863 |
Postpartum haemorrhage | 51.3% | 0.49 to 0.54 | 7863 |
Child care | 43.4% | 0.41 to 0.46 | 7863 |
Neonatal and maternal care | 44.1% | 0.42 to 0.47 | 7863 |
Child, neonatal and maternal care | 21.7% | 0.20 to 0.23 | 7863 |
Health worker attendance | |||
Doctors | 71.0% | 0.64 to 0.78 | 1223 |
Clinical officers | 65.0% | 0.59 to 0.71 | 2277 |
Nurses | 70.9% | 0.68 to 0.73 | 5381 |
Community health workers | 74.0% | 0.71 to 0.77 | 3778 |
Drugs available | |||
Oral rehydration salts (ORS) | 84.4% | 0.82 to 0.87 | 7856 |
Antibiotics for pneumonia | 69.1% | 0.66 to 0.72 | 7854 |
ACT | 77.5% | 0.75 to 0.80 | 4790 |
Oxytocin | 62.3% | 0.60 to 0.65 | 6438 |
ORS, antibiotics, oxytocin | 48.6% | 0.46 to 0.51 | 6436 |
Column 1 reports the underlying components of the care readiness estimation reported in table 5. The unit of analysis is the facility. The estimates in the tables are (unweighted) mean outcomes across countries, with the country means calculated using country-specific sampling weights. Column 2 reports number of facilities. See notes to table 5 for details.
ACT, artemisinin-based combination therapy.